A senior NIH scientist and his research fellow were charged with smuggling vials of deactivated mpox virus into the country from Africa and lying about it.
Vetenskapsnyheter
Longevity startup NewLimit plans to launch its first clinical trial of a liver medicine after raising a staggering $435 million in new funding.
Abivax's ulcerative colitis data, Fulcrum's scrapped sickle cell drug, and more biotech news from The Readout
Lilly gave hospitals participating in a federal drug discount program five days to submit claims data or it will stop the price breaks
Medicaid work requirements, fast-tracked funding for experimental Ebola vaccines, and more health news from Morning Rounds
Growing legislative scrutiny across multiple states targets the corporate structure underlying most direct-to-consumer telehealth businesses.
It’s time to rethink and redesign how patients enter the health care system altogether, writes emergency physician Iyesatta Massaquoi Emeli.
States are racing to implement the new requirements by the start of next year.
Eli Lilly has told more than 1,000 hospitals participating in the 340B drug discount program to submit claims data over the next five days — or lose price breaks.
With no licensed vaccines available to protect against the Ebola virus currently spreading in the Congo, efforts are underway to fast-track development of at least three vaccines.
Abivax said its experimental treatment for ulcerative colitis showed significant efficacy in a closely watched trial, but shares of the company tanked on safety concerns.
Here is some of what you may have missed from the world's largest cancer research meeting.
At the world's largest cancer research meeting, new data were plentiful. But this year, there was also a focus on grief.
The FDA has missed a self-imposed deadline to ban the use of electrical shock devices in people with intellectual disabilities.
We've been asking Medicare for weeks about the cost of giving seniors $50 obesity drugs.
Detailed study data for a pancreatic cancer treatment from Revolution Medicines confirmed it increased overall survival, from 13.2 months to 6.7 months
“You have to understand a person's belief if you want to address it,” Deva Sharma says on the “First Opinion Podcast” about requests for unvaccinated donor blood.
Eli Lilly announces two China deals, Akeso's lung cancer bispecific payoff, and more biotech news from The Readout
The Trump administration disregards infectious disease playbook, CEPI offers vaccine funding, and other health news from Morning Rounds
The French pharma firm Servier is buying an experimental muscular dystrophy drug from Edgewise Therapeutics for $1.55 billion upfront.
Congress must incentivize more physicians (and their employers) to join the military medical corps, writes the former attending physician to Congress.
A compound named “substance God help me” by its longtime champion could benefit from RFK Jr.'s favorable views on using peptides.
Why are residency programs disciplining and dismissing trainees in a system funded to train them?
Older adults on Medicare can get Wegovy and Zepbound for $50 a month, starting in July. But the agency still is not sharing how much this will cost taxpayers.
Two years after General Catalyst said it was buying Ohio safety-net hospital Summa Health, executives shed light on how the “transformation” is going.